Recent Advances in Scaffold Hopping.

Scaffold hopping refers to the computer-aided search for active compounds containing different core structures, which is a topic of high interest in medicinal chemistry. Herein foundations and caveats of scaffold hopping approaches are discussed and recent methodological developments analyzed. Despite the conceptual prevalence of pharmacophore methods for scaffold hopping, a variety of computational approaches have been successfully applied. In recent years, scaffold hopping calculations are increasingly carried out at the level of scaffolds rather than compounds, and scaffold queries increasingly abstract from chemical structures. In addition, relationships between compounds, scaffolds, and biological activities are beginning to be globally explored, beyond individual applications. Going forward, computational scaffold hopping is thought to benefit from the consideration of new scaffold concepts and the development of methods capable of guiding search calculations toward scaffolds that are likely to represent potent compounds.

[1]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[2]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[3]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[4]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[5]  Andrew I Su,et al.  HierS: hierarchical scaffold clustering using topological chemical graphs. , 2005, Journal of medicinal chemistry.

[6]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[7]  Stefan Wetzel,et al.  Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.

[8]  Julen Oyarzabal,et al.  Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonists. , 2009, Journal of medicinal chemistry.

[9]  P Schneider,et al.  Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing. , 2009, Current medicinal chemistry.

[10]  Hanna Geppert,et al.  Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation , 2010, J. Chem. Inf. Model..

[11]  J. Bajorath,et al.  Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. , 2010, Journal of medicinal chemistry.

[12]  J. Bajorath,et al.  Global assessment of scaffold hopping potential for current pharmaceutical targets , 2010 .

[13]  G. Hessler,et al.  The scaffold hopping potential of pharmacophores. , 2010, Drug discovery today. Technologies.

[14]  Alexander Klenner,et al.  'Fuzziness' in pharmacophore-based virtual screening and de novo design. , 2010, Drug discovery today. Technologies.

[15]  Jürgen Bajorath.  Computational chemistry in pharmaceutical research: at the crossroads , 2011, Journal of Computer-Aided Molecular Design.

[16]  Jürgen Bajorath,et al.  Computational medicinal chemistry. , 2011, Journal of medicinal chemistry.

[17]  Hanna Geppert,et al.  Development of a Method To Consistently Quantify the Structural Distance between Scaffolds and To Assess Scaffold Hopping Potential , 2011, J. Chem. Inf. Model..

[18]  Obdulia Rabal,et al.  Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors , 2012, PloS one.

[19]  Peter S. Kutchukian,et al.  Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.

[20]  Anders Wallqvist,et al.  Classification of scaffold-hopping approaches. , 2012, Drug discovery today.

[21]  Peter Ertl,et al.  IADE: a system for intelligent automatic design of bioisosteric analogs , 2012, Journal of Computer-Aided Molecular Design.

[22]  Peter Ertl,et al.  Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping. , 2012, Bioorganic & medicinal chemistry.

[23]  H. V. van Vlijmen,et al.  Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data. , 2012, Journal of medicinal chemistry.

[24]  Ansgar Schuffenhauer,et al.  Computational methods for scaffold hopping , 2012 .

[25]  Jürgen Bajorath,et al.  Systematic assessment of scaffold distances in ChEMBL: prioritization of compound data sets for scaffold hopping analysis in virtual screening , 2012, Journal of Computer-Aided Molecular Design.

[26]  Sarah R. Langdon,et al.  Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors , 2013, J. Chem. Inf. Model..

[27]  Thierry Kogej,et al.  Scaffold Hopping by Fragment Replacement , 2013, J. Chem. Inf. Model..

[28]  T. Hirokawa,et al.  Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin A. , 2014, Chemical communications.

[29]  Ruben Abagyan,et al.  Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping. , 2014, Future medicinal chemistry.

[30]  Peter Ertl,et al.  Intuitive Ordering of Scaffolds and Scaffold Similarity Searching Using Scaffold Keys , 2014, J. Chem. Inf. Model..

[31]  Chang-Guo Zhan,et al.  Application of the 4D Fingerprint Method with a Robust Scoring Function for Scaffold-Hopping and Drug Repurposing Strategies , 2014, J. Chem. Inf. Model..

[32]  G. Maggiora,et al.  Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.

[33]  Jürgen Bajorath,et al.  Quantifying the Tendency of Therapeutic Target Proteins to Bind Promiscuous or Selective Compounds , 2015, PloS one.

[34]  K. Scearce-Levie,et al.  Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12). , 2015, Journal of medicinal chemistry.

[35]  Obdulia Rabal,et al.  Novel Scaffold Fingerprint (SFP): Applications in Scaffold Hopping and Scaffold-Based Selection of Diverse Compounds , 2015, J. Chem. Inf. Model..

[36]  C. Bissantz,et al.  Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach. , 2015, Journal of medicinal chemistry.

[37]  Jürgen Bajorath,et al.  Analog series-based scaffolds: computational design and exploration of a new type of molecular scaffolds for medicinal chemistry , 2016, Future science OA.

[38]  Robert Damoiseaux,et al.  3D Chemical Similarity Networks for Structure-Based Target Prediction and Scaffold Hopping. , 2016, ACS chemical biology.

[39]  Jürgen Bajorath,et al.  Computational Exploration of Molecular Scaffolds in Medicinal Chemistry. , 2016, Journal of medicinal chemistry.